A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial

Background: Heavy menstrual bleeding (HMB) is a common problem, yet evidence to inform decisions about initial medical treatment is limited. Objectives: To assess the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) (Mirena®, Bayer) compa...

Full description

Bibliographic Details
Main Authors: Gupta, Janesh K., Daniels, Jane P., Middleton, Lee J., Pattison, Helen M., Prileszky, Gail, Roberts, Tracy E., Sanghera, Sabina, Barton, Pelham, Gray, Richard, Kai, Joe
Format: Article
Published: NIHR Health Technology Assessment Programme 2015
Subjects:
Clinical Effectiveness; Cost-Effectiveness; levonorgestrel-releasing intrauterine system; Menorrhagia; Randomised Controlled Trial; ECLIPSE trial; Primary Care
Online Access:https://eprints.nottingham.ac.uk/47618/

Internet

https://eprints.nottingham.ac.uk/47618/

Similar Items